SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Royalty / Mark-up on Cost of Goods Sold / Earn-Out Revenue [Abstract]
Number of quarters after which revenue is recognized (in quarters)			1
Number of days after calendar year, after which payments and report are received (in days)			90 days
Accounts receivable and Allowance for Doubtful Accounts [Abstract]
Number of major customers			2
Allowance for doubtful accounts	$ 30,095	$ 30,095	$ 30,095	$ 30,095
Accounts receivable	2,820,845		2,820,845		3,236,917
Reimbursable Third Party Development Costs [Abstract]
Accrued patent costs	74,000		74,000
Stock-Based Compensation [Abstract]
Number of stock-based compensation plans in effect			2
Value of stock options granted	109,000
Fair value assumptions used to estimate the value options [Abstract]
Volatility (in hundredths)			54.00%
Risk free rate (in hundredths)			0.69%
Average exercise period			5 years
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	135,879	131,209	175,685	264,907
Total Number of Shares
Options Outstanding, beginning of period (in shares)			1,261,425
Granted (in shares)			15,000
Forfeited (in shares)			0
Exercised (in shares)			24,000
Expired (in shares)			0
Options Outstanding, end of period (in shares)	1,252,425		1,252,425
Exercisable, end of period (in shares)	1,172,425		1,172,425
Weighted Average Exercise Price
Options Outstanding, beginning of period (in dollars per share)			$ 8.27
Granted (in dollars per share)			$ 15.75
Forfeited (in dollars per share)			$ 0
Exercised (in dollars per share)			$ 3.25
Expired (in dollars per share)			$ 0
Options Outstanding, end of period (in dollars per share)	$ 8.46		$ 8.46
Exercisable, end of period (in dollars per share)	$ 7.48		$ 7.48
Proceeds from stock option exercises			78,000	72,450
Aggregate intrinsic value of options outstanding and exercisable	13,200,000		13,200,000
Closing price of common stock (in dollars per share)	$ 18.78		$ 18.78
Unrecognized compensation cost related to non-vested stock options outstanding	79,000		79,000
Weighted-average period over which unrecognized compensation cost to be recognized			9 months
Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life of property, plant and equipment (in years)			5 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life of property, plant and equipment (in years)			10 years
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	122,679	25,457	144,817	52,573
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	13,200	105,752	30,868	212,334
DFB Biotech Inc [Member]
Accounts receivable and Allowance for Doubtful Accounts [Abstract]
Accounts receivable	1,300,000		1,300,000
Auxilium [Member]
Accounts receivable and Allowance for Doubtful Accounts [Abstract]
Accounts receivable	1,500,000		1,500,000
Recurring [Member] | Cash and Cash Equivalents [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	3,788,173		3,788,173
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	3,788,173		3,788,173
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Recurring [Member] | Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Recurring [Member] | Certificates of Deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,000,000		5,000,000
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,000,000		5,000,000
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0		0
Recurring [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0		$ 0